Biodesix, Inc. Common Stock — informes financieros trimestrales (NASDAQ:BDSX) | MetaTrader

Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas

Market Capitalization 139.04 M
Employee 334
Founded 2005
CEO N/A
Website www.biodesix.com
Headquarter Delaware, United States
FIGI BBG001J2LMV6
Industry Diagnóstico y pruebas

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

Ratio precio/beneficio

-3.66

Relación precio/flujo de caja

1.2

Noticias

Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Canaccord eleva el precio objetivo de Biodesix a 22 dólares

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates

Are Medical Stocks Lagging Aura Biosciences (AURA) This Year?

LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?

Here's Why You Should Add DexCom Stock to Your Portfolio Now

MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Brookdale Senior Q1'26 Sneak Peek: Occupancy Volume Rises to 82.1%